Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Reactive astrocytic S1P3 signaling modulates the blood-tumor barrier in brain metastases.

Gril B, Paranjape AN, Woditschka S, Hua E, Dolan EL, Hanson J, Wu X, Kloc W, Izycka-Swieszewska E, Duchnowska R, Pęksa R, Biernat W, Jassem J, Nayyar N, Brastianos PK, Hall OM, Peer CJ, Figg WD, Pauly GT, Robinson C, Difilippantonio S, Bialecki E, Metellus P, Schneider JP, Steeg PS.

Nat Commun. 2018 Jul 13;9(1):2705. doi: 10.1038/s41467-018-05030-w.

2.

IDH mutation is paradoxically associated with higher 18F-FDOPA PET uptake in diffuse grade II and grade III gliomas.

Verger A, Metellus P, Sala Q, Colin C, Bialecki E, Taieb D, Chinot O, Figarella-Branger D, Guedj E.

Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1306-1311. doi: 10.1007/s00259-017-3668-6. Epub 2017 Mar 14.

PMID:
28293705
3.

Neurosurgical and radiosurgical decision making in brain metastasis patients in the area of targeted therapies?

Metellus P, Bialecki E, Le Rhun E, Dhermain F.

Chin Clin Oncol. 2015 Jun;4(2):19. doi: 10.3978/j.issn.2304-3865.2015.06.02. Review.

4.

Targeted delivery of α-galactosylceramide to CD8α+ dendritic cells optimizes type I NKT cell-based antitumor responses.

Macho-Fernandez E, Cruz LJ, Ghinnagow R, Fontaine J, Bialecki E, Frisch B, Trottein F, Faveeuw C.

J Immunol. 2014 Jul 15;193(2):961-9. doi: 10.4049/jimmunol.1303029. Epub 2014 Jun 9.

5.

Spleen-resident CD4+ and CD4- CD8α- dendritic cell subsets differ in their ability to prime invariant natural killer T lymphocytes.

Bialecki E, Macho Fernandez E, Ivanov S, Paget C, Fontaine J, Rodriguez F, Lebeau L, Ehret C, Frisch B, Trottein F, Faveeuw C.

PLoS One. 2011;6(10):e26919. doi: 10.1371/journal.pone.0026919. Epub 2011 Oct 31.

6.

Activation of invariant Natural Killer T lymphocytes in response to the α-galactosylceramide analogue KRN7000 encapsulated in PLGA-based nanoparticles and microparticles.

Macho Fernandez E, Chang J, Fontaine J, Bialecki E, Rodriguez F, Werkmeister E, Krieger V, Ehret C, Heurtault B, Fournel S, Frisch B, Betbeder D, Faveeuw C, Trottein F.

Int J Pharm. 2012 Feb 14;423(1):45-54. doi: 10.1016/j.ijpharm.2011.04.068. Epub 2011 May 14.

PMID:
21575695
7.

Potential role of invariant NKT cells in the control of pulmonary inflammation and CD8+ T cell response during acute influenza A virus H3N2 pneumonia.

Paget C, Ivanov S, Fontaine J, Blanc F, Pichavant M, Renneson J, Bialecki E, Pothlichet J, Vendeville C, Barba-Spaeth G, Huerre MR, Faveeuw C, Si-Tahar M, Trottein F.

J Immunol. 2011 May 15;186(10):5590-602. doi: 10.4049/jimmunol.1002348. Epub 2011 Apr 13. Erratum in: J Immunol. 2011 Aug 1;187(3):1515. Barba-Speath, Giovanna [corrected to Barba-Spaeth, Giovanna].

8.

Role of marginal zone B lymphocytes in invariant NKT cell activation.

Bialecki E, Paget C, Fontaine J, Capron M, Trottein F, Faveeuw C.

J Immunol. 2009 May 15;182(10):6105-13. doi: 10.4049/jimmunol.0802273.

9.

Role of invariant NK T lymphocytes in immune responses to CpG oligodeoxynucleotides.

Paget C, Bialecki E, Fontaine J, Vendeville C, Mallevaey T, Faveeuw C, Trottein F.

J Immunol. 2009 Feb 15;182(4):1846-53. doi: 10.4049/jimmunol.0802492.

10.

Diagnosis of hepatocellular carcinoma.

Bialecki ES, Di Bisceglie AM.

HPB (Oxford). 2005;7(1):26-34. doi: 10.1080/13651820410024049.

11.

Comparison of liver biopsy and noninvasive methods for diagnosis of hepatocellular carcinoma.

Bialecki ES, Ezenekwe AM, Brunt EM, Collins BT, Ponder TB, Bieneman BK, Di Bisceglie AM.

Clin Gastroenterol Hepatol. 2006 Mar;4(3):361-8.

PMID:
16527701
12.

Clinical presentation and natural course of hepatocellular carcinoma.

Bialecki ES, Di Bisceglie AM.

Eur J Gastroenterol Hepatol. 2005 May;17(5):485-9. Review.

PMID:
15827437
13.

Decreased expression of peroxisome proliferator activated receptor gamma in cftr-/- mice.

Ollero M, Junaidi O, Zaman MM, Tzameli I, Ferrando AA, Andersson C, Blanco PG, Bialecki E, Freedman SD.

J Cell Physiol. 2004 Aug;200(2):235-44.

PMID:
15174093
14.

Sildenafil relieves priapism in patients with sickle cell disease.

Bialecki ES, Bridges KR.

Am J Med. 2002 Aug 15;113(3):252. No abstract available.

PMID:
12208390

Supplemental Content

Loading ...
Support Center